{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Broomfield",
      "state": "CO",
      "country": "United States",
      "classification": "Class I",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "65200",
      "recalling_firm": "Sandoz Incorporated",
      "address_1": "2555 W Midway Blvd",
      "address_2": "N/A",
      "postal_code": "80020-1632",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Press Release",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-832-2013",
      "product_description": "Methotrexate Injection, USP, Preservative-Free, 1 g/40 mL (25 mg/mL), 40 mL Single Dose Vial, Rx only, Manufactured for: Sandoz Inc., Princeton, NJ  08540; Manufactured by: EBEWE Pharma Ges.m.b.H. Nfg.KG, A-4866 Unterach, AUSTRIA, NDC 66758-041-01.",
      "product_quantity": "1,635 vials",
      "reason_for_recall": "Presence of Particulate Matter: Found during examination of  retention samples.",
      "recall_initiation_date": "20130520",
      "center_classification_date": "20130802",
      "termination_date": "20140129",
      "report_date": "20130814",
      "code_info": "Lot #: CL0996, Exp 12/13; and CJ4948, Exp 05/13"
    }
  ]
}